Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau
Status:
Not yet recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
This study will look at the effects of lemborexant on Alzheimer's disease biomarkers found in
the cerebrospinal fluid (CSF) and blood in individuals who are poor sleepers